What does Société Médicale Cox-Cuvelier do?

Société Médicale Cox-Cuvelier is a specialist medical practice in Herve. Private Limited, started on 24 December 2008, 1 establishment.

What is the address of Société Médicale Cox-Cuvelier?

The registered office of Société Médicale Cox-Cuvelier is located at Rue du Château 47, 4650 Herve.

Is Société Médicale Cox-Cuvelier still active?

Yes. According to the CBE (18 September 2026) Société Médicale Cox-Cuvelier is active, legal situation “Normale toestand”, started on 24 December 2008.

Is Société Médicale Cox-Cuvelier registered on Peppol?

Yes, Société Médicale Cox-Cuvelier is registered on the Peppol network with ID 0208:0808703747.

What is the enterprise number of Société Médicale Cox-Cuvelier?

The enterprise number of Société Médicale Cox-Cuvelier is BE0808703747.

When was Société Médicale Cox-Cuvelier founded?

Société Médicale Cox-Cuvelier was founded on 24 December 2008.

Who are the directors of Société Médicale Cox-Cuvelier?

According to the 2024 annual accounts, the directors of Société Médicale Cox-Cuvelier are: Jonathan COX.

Is Société Médicale Cox-Cuvelier a reliable company?

Databakkes does not pass judgement; this is what the sources say: Active according to the CBE since 24 December 2008; 4 annual accounts filed, latest fiscal year 2024; 1 directors known from the annual account.

How much profit did Société Médicale Cox-Cuvelier make in 2024?

Société Médicale Cox-Cuvelier posted a profit after taxes of € 142,622 in financial year 2024.

What is the revenue of Société Médicale Cox-Cuvelier?

As a small company, Société Médicale Cox-Cuvelier is not required to publish revenue in its annual accounts. In financial year 2024, its added value was € 338,306.

Société Médicale Cox-Cuvelier (Private Limited) - Herve

Dossier Société Médicale Cox-Cuvelier, printed on 18 September 2026 from databakkes.be/en/0808703747/societe-medicale-cox-cuvelier. Sources: CBE, National Bank of Belgium, Belgian Official Gazette.

Financials

Financial year 2024

Société Médicale Cox-Cuvelier from Herve, company number BE0808703747, closed financial year 2024 with a result of € 142,622 after tax. For that financial year Société Médicale Cox-Cuvelier recorded a gross margin of € 338,306 and equity of € 547,628. Compared with financial year 2023, the result moved from € 139,993 to € 142,622. Profitable, and profit is growing. The buffer is growing. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on August 22, 2025.

What it is worth Growing

€ 547,628

▲ 29% vs 2023

Assets minus debts, by the books. What is left if everything were sold and paid today.

Profit Growing

€ 142,622

▲ 2% vs 2023

Profit after tax over the fiscal year.

Cash in the bank

€ 411

Cash and bank balances on the last day of the fiscal year.

Where the profit goes Pays out

€ 20,000 paid out

14 % of the profit went to the shareholders, the rest stayed in the company.

People and assets in 2024

Vehicles and equipment

€ 118,485

▲ € 103,626 vs 2023

Book value of vehicles, furniture and equipment.

Debts at end 2024

Bank debt ≈ 7 years to go The accounts give the long-term loan and the part due within the year. The remainder divided by that part is the number of years at an equal pace; a new loan or early repayment changes it.

€ 835,396

▲ 2% vs 2023

€ 125,619 is repaid this year. At this pace the long-term loan is gone in ≈ 7 years.

Owed to suppliers

€ 24,142

Supplier invoices still open on the last day of the fiscal year.

Taxes

€ 37,502

▲ 57% vs 2023

Corporate tax and VAT still to pay. No wage debt: nothing outstanding to staff or social security.

Want to see how much further we take a dossier in the Pro version? Open the free De Lijn example and give feedback →

Key figures per fiscal year Download key figures (CSV)
	2021	2022	2023	2024	Change 2023 → 2024
Revenue	-	-	€ 488,224 Revenue 2023: € 488,224 First fiscal year in the series	-
Gross margin	€ 275,701 Gross margin 2021: € 275,701 First fiscal year in the series	€ 230,369 Gross margin 2022: € 230,369 ▼ 16% vs 2021 (€ 275,701) Unfavourable step	€ 328,542 Gross margin 2023: € 328,542 ▲ 43% vs 2022 (€ 230,369) Favourable step	€ 338,306 Gross margin 2024: € 338,306 ▲ 3% vs 2023 (€ 328,542) Favourable step	▲ 3%
Profit after taxes	€ 83,515 Profit after taxes 2021: € 83,515 First fiscal year in the series	€ 71,648 Profit after taxes 2022: € 71,648 ▼ 14% vs 2021 (€ 83,515) Unfavourable step	€ 139,993 Profit after taxes 2023: € 139,993 ▲ 95% vs 2022 (€ 71,648) Favourable step	€ 142,622 Profit after taxes 2024: € 142,622 ▲ 2% vs 2023 (€ 139,993) Favourable step	▲ 2%
Equity	€ 340,365 Equity 2021: € 340,365 First fiscal year in the series	€ 352,013 Equity 2022: € 352,013 ▲ 3% vs 2021 (€ 340,365) Favourable step	€ 425,006 Equity 2023: € 425,006 ▲ 21% vs 2022 (€ 352,013) Favourable step	€ 547,628 Equity 2024: € 547,628 ▲ 29% vs 2023 (€ 425,006) Favourable step	▲ 29%
Total debts	€ 1,034,166 Total debts 2021: € 1,034,166 First fiscal year in the series	€ 913,760 Total debts 2022: € 913,760 ▼ 12% vs 2021 (€ 1,034,166) Favourable step	€ 872,765 Total debts 2023: € 872,765 ▼ 4% vs 2022 (€ 913,760) Favourable step	€ 897,041 Total debts 2024: € 897,041 ▲ 3% vs 2023 (€ 872,765) Unfavourable step	▲ 3%
Cash	€ 32,158 Cash 2021: € 32,158 First fiscal year in the series	-	-	€ 411 Cash 2024: € 411 First fiscal year in the series
Land & buildings	€ 1,047,161 Land & buildings 2021: € 1,047,161 First fiscal year in the series	€ 1,013,721 Land & buildings 2022: € 1,013,721 ▼ 3% vs 2021 (€ 1,047,161) Unchanged	€ 1,000,260 Land & buildings 2023: € 1,000,260 ▼ 1% vs 2022 (€ 1,013,721) Unchanged	€ 953,480 Land & buildings 2024: € 953,480 ▼ 5% vs 2023 (€ 1,000,260) Unchanged	▼ 5%
Retained profit	€ 334,165 Retained profit 2021: € 334,165 First fiscal year in the series	€ 345,813 Retained profit 2022: € 345,813 ▲ 3% vs 2021 (€ 334,165) Favourable step	€ 418,806 Retained profit 2023: € 418,806 ▲ 21% vs 2022 (€ 345,813) Favourable step	€ 541,428 Retained profit 2024: € 541,428 ▲ 29% vs 2023 (€ 418,806) Favourable step	▲ 29%
Dividend	€ 0 Dividend 2021: € 0 First fiscal year in the series	€ 60,000 Dividend 2022: € 60,000 Unchanged (€ 0) Unchanged	€ 67,000 Dividend 2023: € 67,000 ▲ 12% vs 2022 (€ 60,000) Unchanged	€ 20,000 Dividend 2024: € 20,000 ▼ 70% vs 2023 (€ 67,000) Unchanged	▼ 70%
Bank debt	€ 978,011 Bank debt 2021: € 978,011 First fiscal year in the series	€ 888,504 Bank debt 2022: € 888,504 ▼ 9% vs 2021 (€ 978,011) Favourable step	€ 820,935 Bank debt 2023: € 820,935 ▼ 8% vs 2022 (€ 888,504) Favourable step	€ 835,396 Bank debt 2024: € 835,396 ▲ 2% vs 2023 (€ 820,935) Unfavourable step	▲ 2%
Balance sheet total	€ 1,374,531 Balance sheet total 2021: € 1,374,531 First fiscal year in the series	€ 1,265,773 Balance sheet total 2022: € 1,265,773 ▼ 8% vs 2021 (€ 1,374,531) Unchanged	€ 1,297,771 Balance sheet total 2023: € 1,297,771 ▲ 3% vs 2022 (€ 1,265,773) Unchanged	€ 1,444,669 Balance sheet total 2024: € 1,444,669 ▲ 11% vs 2023 (€ 1,297,771) Unchanged	▲ 11%

Key figures of Société Médicale Cox-Cuvelier, fiscal years 2021 to 2024, from the annual accounts filed with the National Bank of Belgium.The annual account for fiscal year 2025 has not been filed yet; it was expected before 31 July 2026.

What happened to Société Médicale Cox-Cuvelier?

What happened at Société Médicale Cox-Cuvelier in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

Aug 22, 2025 New annual accounts for financial year 2024: profit of € 142,622 (▲ 2% vs 2023). filed late Source: NBB ↗
Dec 24, 2008 New establishment in Herve. KBO
Dec 24, 2008 Start of the company according to the CBE. KBO

In short

From € 83,515 profit in 2021 to € 142,622 profit in 2024.

Paid € 178,386 in corporate taxes since 2021.

Best year ever: 2024, with € 142,622 profit.

Paid out € 147,000 in dividends to the owners in total.

Original PDFs at the National Bank ↗

A new publication or filing at Société Médicale Cox-Cuvelier? We notify you, reason included.

Follow Société Médicale Cox-Cuvelier

Databakkes Pro

Know what changes at your customers, suppliers and competitors. Without reading an annual account.

Follow them in one folder Every company in your folder gets this full dossier: household book, all fiscal years, benchmark against companies of the same size.
We alert you, with the reason New annual account, Official Gazette publication or status change: you get what changed and where it says so.
In bulk too, and in ChatGPT and Claude Upload your customer list and get the warning signs back per company. Or ask in your own AI assistant, with this register as the source.

Yes, I want that

See what a followed company gets: the De Lijn dossier

Databakkes Pro is being built. Sign up now and you are first in line for an invitation, with a month to try without a credit card.

My folder 3 companies

De Lijn 8 June 2026 New annual account 2025

filed on 8 June 2026

What was left

€ 20 k ▼ 91%
Money in the bank

€ 178 k ▼ 98%

Open the dossier →
NMBS 8 June 2026 New annual account 2025 What was left ▼ 80%
bpost 18 May 2026 New annual account 2025 What was left from loss to profit

Real filings at the National Bank

Management

Jonathan COX

Société Médicale Cox-Cuvelier

Behind Société Médicale Cox-Cuvelier is Jonathan COX.

See the full network in the app

Directors

According to the 2024 annual accounts

Jonathan COX

Director

Establishments

Establishment units

Physical locations of this company

Registered office

Rue du Château 47

4650 Herve

What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.

Details

Company number: 0808.703.747
VAT number: BE 0808.703.747
Registered office: Rue du Château 47, 4650 Herve
Names & denominations: Société Médicale Cox-Cuvelier
Enterprise type: Rechtspersoon
Legal form: Private limited company
Legal situation: Normale toestand
Start date: 24 December 2008
Peppol: Active · Active since 5 Jan 2026
Activities · NACE: Activiteiten van medisch specialisten

View on CBE Public ↗ Annual accounts (NBB) ↗